Cholecystokinin octapeptide and the daily rhythm of vasopressin and oxytocin release

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 2, 1996, Pages 164-171

  Morawska Barszczewska, J ^a   Guzek, J W ^a   Kaczorowska Skora J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

CCK 8; Daily rhythms; Oxytocin; Vasopressin

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; NEUROHYPOPHYSIS HORMONE; OXYTOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CIRCADIAN RHYTHM; CONTROLLED STUDY; HORMONE RELEASE; HYPOTHALAMUS; MALE; NEUROHYPOPHYSIS; NIGHT; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT; SUNLIGHT; VASOPRESSIN BLOOD LEVEL;

EID: 0029875691     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211439     Document Type: Article

References (44)

1. Beinfeld MC: Cholecystokinin in the central nervous system. Neuropeptides 3: 411-427, 1983.
2. Beinfeld MC, Meyer DK, Brownstein MJ: Cholecystokinin octapeptide in the rat hypothalamo-neurohypophysial system: Nature 18: 92-103, 1975.
3. Burbach JPH, Lui B, Voorhuis TAM, Van Tol HHM: Diurnal variation in vasopressin and oxytocin messenger RNA's in hypothalamic nuclei of the rat. Brain Res 4: 157-160, 1988.
4. Ciosek J, Stempniak B, Orłowska-Majdak M: Thyrotropin-releasing hormone (TRH) inhibits vasopressin release from hypothalamo-neurohypophysial system of rats drinking hypertonic saline. Endocrine Reg. 27: 29-34, 1993.
5. Coccatelli S, Eriksson M, Hökfelt T: Distribution and coexistence of corticotropin-releasing factor- neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polipeptide/peptide, histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49: 309-323, 1989.
6. Crawley JN, Fiske SM, Durieux Ch, Derrien M, Roques BP: Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J Pharmacol Exp Therap 257: 1076-1080, 1991.
7. Cuber JC, Bernard C, Gibard T, Chayvialle JA: Pharmacokinetics and organ catabolism of cholecystokinin in pigs. Regulatory Peptides 26: 203-213, 1989a.
8. Della-Fera MA, Baile CA: CCK-octapeptide injected in CSF and changes in feed intake and rumen motility. Physiol Behav 25: 943-950, 1980.
9. Della-Fera MA, Baile CA: Cholecystokinin octapeptide: Continous picomole injections into cerebral ventricles of sheep suppress feeding. Science 206: 471-473, 1979.
10. Gad SC and Weil CS: Statistics for toxicologists. In: Principles and methods of toxicology, Second Edition, edited by Wallace Hayes, Raven Press, Ltd, New York 1989, pp 435-483.
11. Gauquelin G, Geelen G, Louis F, Allevard AM, Meunier G, Cuisinaud G, Benjanet S, Seidan NG, Chretin M, Legros JJ, Gharib C: Presence of vasopressin, oxytocin and neurophysin in the retina of mammals, effect of light and darkness, comparison with the neuropeptide content of the neurohypophysis and the pineal gland. Peptides 4: 509-515, 1983.
12. 131J-labelled human growth hormone of a high specific radioactivity. Biochem J 89: 114-123, 1963.
13. Guzek JW, Morawska J: Cholecystokinin affects water intake as well as neurohypophysial storage of vasopressin and oxytocin in the rat. Exp Clin Endocrinol 88: 200-206, 1986.
14. König A, Meyer A: Tagesperiodische Schwankungen der Urinausscheidung und des Adiuretingehaltes im Hypophysenhinterlappen männlicher Wistar-Ratten. Acta Endocrinol 54: 275-281, 1967.
15. Landgraf R: Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay. Endocrinology 78: 191-204, 1981.
16. Landgraf R, Hacker R, Buhl H: Plasma vasopressin and oxytocin changes in response to exercise and during the day-night cycle in man. Endokrinologie 8: 281-291, 1982.
17. Lewandowska A, Gtowacka A, Guzek JW: The vasopressin and oxytocin neurohypophysial content as influenced by bleeding or dehydration: Effect of cholecystokinin octapeptide. J Physiol Pharmacol 43: 153-165, 1992.
18. Lewandowska A, Szyburska I, Guzek JW: Atrial Natriuretic peptide inhibits neurohypohysial hormones' release in the rat (in vitro and in vivo studies). J Physiol Pharmacol 43: 77-86, 1992.
19. Marley PD, Lightman SL, Forsling ML, Todd K; Goedert M.; Rehfeld JF, Emson PC: Localization and actions of cholecystokinin in the rat pituitary neurointermediate lobe. Endocrinology 114: 1902-1911, 1984.
20. McCann MJ, Verbalis J, Stricker EM: Li and CCK inhibit gastric emptying and feeding and stimulate OT secretion in rats. Am J Physiol R463-468, 1989.
21. Meister B, Cortes R, Villar MJ, Schalling M, Hökfelt T: Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: Comparison between messenger RNA and peptide/protein levels. Cell Tissue Res 260: 279-297, 1990.
22. Moore G, Lutterodt A, Burford G, Lederis K: A highly specific antiserum for arginine vasopressin. Endocrinology 101: 1421-1435, 1977.
23. Morawska-Barszczewska J, Lewandowska A, Guzek JW: Neurohypophysial response to peptides of cholecystokinin family: in vivo and in vitro studies. Pat Pol 45: 163-171, 1994.
24. Nagain C, Rozé C: Les récepteurs de la cholécystokinine. Gastroenterol Clin Biol 15: 735-743, 1991.
25. Parrot RF, Ebenezer IS, Baldwin BA, Forsling ML: Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release. Exp Physiol 76: 625-531, 1991.
26. Perlow MJ, Reppert SM, Artman HA, Fisher DA, Seif SM, Robinson AG: Oxytocin, vasopressin and oestrogen stimulated neurophysin: Daily patterns of concentration in cerebrospinal fluid. Science 216: 1416-1418, 1982.
27. Renaud LP, Bourquet CW: Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Progress in Neurobiology 36: 131-169, 1991.
28. Renaud LP, Tang M, McCann MJ, Stricker EM, Verbalis JG: Cholecystokinin and gastric distension activate oxytocinergic cells in rat hypothalamus. Am J Physiol 253: R661-665, 1987.
29. Reppert SM, Coleman RJ, Heath HW, Keutmann HT: Orcadian properties of vasopressin and melatonin rhythms in cat cerebrospinal fluid. Am J Physiol 243: E489-498, 1982.
30. Reppert SM, Perlow MJ, Artman HG, Ungerleider LG, Fisher DA, Klein DC: The circadian rhythm of oxytocin in primate cerebrospinal fluid: Effects of destruction of the suprachiasmatic nuclei. Brain Res 307: 384-385, 1984.
31. Reuss S: Photoperiod effects on bombesin- and cholecystokinin-like immunoreactivity in the suprachiasmatic nuclei of Djungarian hamster (Phodopus sungorus). Neuroscience Letters 128: 13-16, 1991.
32. Schick RR, Yaksh TL, Roddy DR, Go VLW: Release of hypothalamic cholecystokinin in cats: effect on nutrient and volume loading. Am J Physiol 256: R243-254, 1989.
33. Schwartz WJ, Coleman RJ, Reppert SM: A daily vasopressin rhythm in rat cerebrospinal fluid. Brain Res 6: 105-112, 1983.
34. Seckl JR, Lightman SL: Diurnal rhythm of vasopressin but not oxytocin in the cerebrospinal fluid of the goat: Lack of association with plasma cortisol rhythm. J Endocrinol 114: 477-482, 1987.
35. Ueta Y, Kannan H, Higuchi T, Negoro H, Yamashita H: CCK-8 excites oxytocin-secreting neurons in the paraventricular nucleus in rats - possible involvement of noradrenergic pathway. Brain Res Bull 32: 453-459, 1993.
36. van den Pol AN, Tsujimoto KL: Neurotransmitters of the hypothalamic suprachiasmatic nucleus: Immunocytochemical analysis of 25 neuronal antigens. Neuroscience 15: 1049-1086, 1985.
37. Vanderhaeghen JJ, Lotstra F, De Mey J, Gilles C: Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc Natl Acad Sci USA 77: 1190-1194, 1980.
38. Vanderhaeghen JJ, Lotstra F, Vandesande F, Dierick K: Coexistence of cholecystokinin and oxytocin-neurophysin in some magnocellular hypothalamo-hypophyseal neurons. Cell Tissue Res 221: 227-231, 1981.
39. 3H] cholecystokining as radioligand. J Neuroscience 4: 1021-1033, 1984.
40. Verbalis JG, McCann MJ, McHale CM, Stricker EM: Oxytocin secretion in response to cholecystokinin and food: Differentation of nausea from satiety. Science 232: 1417-1419, 1986.
41. Vijayan E, Samson WK, McCann SM: In vivo and in vitro effect of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat. Brain Res 172: 295-302, 1979.
42. Weitzman RE, Fisher DA: Arginine vasopressin metabolism in dogs. I. Evidence for a receptor-mediated mechanism. Am J Physiol 235: E591-E597, 1978.
43. Wenogle LP, Steel DJ, Petrack B: Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe. Life Sci 36: 1485-1492, 1985.
44. Windle RJ, Forsling ML, Guzek JW: Daily rhythms in the hormone content of the neurohypophysial system and release of oxytocin and vasopressin in the male rat: Effect of constant light. J Endocrinol 133: 283-290, 1992.